Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1997-12-18
1999-11-09
Jarvis, William R. A.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 31557
Patent
active
059815930
ABSTRACT:
The present invention relates to the treatment of impotence, and, more particular, to devices for the delivery of a clinicially effective amount of prostaglandin PGE.sub.2 through the urethral mucosa for the treatment of impotence. The device is a solid or porous wand coated with an effective amount of PGE.sub.2 in a suitable carrier. The wand is sized for insertion into the urethra and the subsequent release and absorption of the PGE.sub.2 through the urethral mucosa. In the alternative, the device is a tubular urethral insert through which a unit dosage of a liquid composition containing the PGE.sub.2 is delivered.
REFERENCES:
patent: 4311707 (1982-01-01), Birmbaum et al.
patent: 4801587 (1989-01-01), Voss et al.
patent: 4955878 (1990-09-01), See et al.
patent: 5242391 (1993-09-01), Place et al.
Andersen et a., Molecular Basis for Prostaglandin Potency, III. Tests of the Significance of the "Hairpin Conformation" in Biorecognition Phenomena, Prostaglandins, vol. 22, No. 5, pp. 841-855, Nov. 1981.
Artoux, Michelle J., "Alprostadil in Impotence," DICP, The Annals of Pharmacotherapy, 25:363-365, Apr. 1991.
Bernard et al., "The Roles of Urologist and Patient in Autoinjection Therapy for Erectile Dysfunction," Contemporary Urology, pp. 21-26, Jan./Feb. 1990.
Burnakis, Thomas, "Amyl Nitrite for the Treatment of Penile Tumescence," Hospital Pharmacy, vol. 26, 343-344, Apr. 1991.
Catanzarite, et al., "Prostaglandins: Mundane and Visionary Applications," Contemporary OB/GYN, pp. 21-41, Oct. 1987.
Cavallini, Giorgio, "Minoxidil vs. Nitroglycerine: A Perspective Double Blind Controlled Trial in Transcutaneous Erection Facilitation for Organic Impotence," The Journal of Urology, 146 :50-53, Jul. 1991.
Dray et al., "Prostaglandins of the E Series Inhibit Release of Noradrenaline in Rat Hypothalamus by a Mechanism Unrelated to Classical .alpha..sub.2, Adrenergic Presynaptic Inhibition," Neuropharmacology, vol. 23 No. 4, pp. 457-462, 1984.
Dunn, C.D.R., "Prostaglandins and Erythropoiesis: Structure/Action Relationships and Identification of the Prostaglandin Responsive Cells," Blut, 42, pp. 307-314, 1981.
Ganong, William F., "Chapter 17, Energy Balance, Metabolism & Nutrition" pp. 229-231, Review of Medical Physiology, 85h Ed., 1977.
Ganong, William F., "Chapter 15. Instinctual Behavior & Emotions, Prostaglandins." p. 187 and Section IV. Endocrinology & Metabolism, Prostaglandins, p. 226, Review of Medical Physiology, 7th Edition, 1975.
Gauger et al., "Comparative Efficacy of Intravaginal Prostaglandin E.sub.2 in the Gel and Suppository Forms for Cervical Ripening," DICP,The Annals of Pharmacotherapy, vol. 25, pp. 456-460, May 1991.
Larock et al., "Organopalladium Approaches to Prostaglandins, Synthesis of PGF.sub.2.alpha. by the Controlled, One-Step, Palladium-Promoted, Intermolecular Coupling of Three Different Alkenes," J. Am. Chem. Soc., 113, 7815-7816, 1991.
Lehinger, Albert, "The Molecular Basis of Cell Structure and Functionl," Biochemistry, Second Edition, 300, 686-687, 1975.
Pasargiklian et al., Clinical, Functional and Pathogenetic Aspects of Bronchial Reactivity to Prostaglandins F.sub.2.alpha., E.sub.1,and E.sub.2, Advances in Prostaglandin and Thromboxane Research, vol. 1, pp. 461-475, 1976.
Takahashi et al., "Glomerular Actions of a Free Radical-Generated Novel Prostaglandin, 8-epi-Prostaglandin F.sub.2.alpha., in the Rat," J. Clin. Invest., vol. 90, 136-141, Jul. 1992.
Windholz, et al., Prostaglandin(s), The Merck Index, pp. 1134-1135, 1983.
Wolfson et al., "Intraurethral Prostaglandin E-2 Cram: A Possible Alternative Treatment for Erectile Dysfunction", Urology, vol. 42, No. 1, Jul. 1993 and Abstract of Article.
Zoutendam et al., "Quantitative Determinatin of Alprostadil (PGE.sub.1) in Bulk Drug and Pharmaceutical For ulations by High-Performance Liquid Chromatography", 283, 273-280, 1984.,
"Prostin E-2," package insert of the Upjohn Company, revised Oct. 1990.
"Hemabat," package insert of the Uphohn Company, Nov. 1989.
"Impotence," Medical Aspects of Human Sexuality, pp. 66-68, May 1991.
Jarvis William R. A.
Ram Michael J.
LandOfFree
Prostaglandin E2 treatment of impotence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin E2 treatment of impotence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin E2 treatment of impotence will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456785